Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non- Small-cell lung cancer: A propensity-matched analysis

Journal of Clinical Oncology

Volumn 32, Issue 23, 2014, Pages 2449-2455

  Landreneau, Rodney J ^a,c   Normolle, Daniel P ^b   Christie, Neil A ^a   Awais, Omar ^a   Wizorek, Joseph J ^a   Abbas, Ghulam ^a   Pennathur, Arjun ^a   Shende, Manisha ^a   Weksler, Benny ^a   Luketich, James D ^a   Schuchert, Matthew J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALGORITHM; ANALYSIS; ANATOMIC SEGMENTECTOMY; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; FEMALE; HUMAN; KAPLAN MEIER METHOD; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SURGERY; SURVIVAL; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; LUNG RESECTION; PATHOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PNEUMONECTOMY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84905860703     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.50.8762     Document Type: Article

References (53)

1. Ginsberg RJ, Rubinstein LV, Lung Cancer Study Group: Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg 60:615-622, 1995
2. Pettiford BL, Schuchert MJ, Santos R, et al: Role of sublobar resection (segmentectomy and wedge resection) in the surgical management of non-small cell lung cancer. Thorac Surg Clin 17:175- 190, 2007
3. Lewis RJ: The role of video-assisted thoracic surgery for carcinoma of the lung: Wedge resection to lobectomy by simultaneous individual stapling. Ann Thorac Surg 56:762-768, 1993
4. Whitson BA, Groth SS, Andrade RS, et al: Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: A populationbased analysis. Ann Thorac Surg 92:1943-1950, 2011
5. Mery CM, Pappas AN, Bueno R, et al: Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 128:237-245, 2005 (Pubitemid 40994479)
6. Jensik RJ, Faber LP, Milloy FJ, et al: Segmental resection for lung cancer: A fifteen year experience. J Thorac Cardiovasc Surg 66:563-572, 1973
7. Warren WH, Faber LP: Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma: Five-year survival and patterns of intrathoracic recurrence. J Thorac Cardiovasc Surg 107:1087-1093, 1994
8. Read RC, Yoder G, Schaeffer RC: Survival after conservative resection for T1 N0 M0 non-small cell lung cancer. Ann Thorac Surg 49:242-247, 1990
9. Okada M, Yoshikawa K, Hatta T, et al: Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann Thorac Surg 71:956- 961, 2001
10. Schuchert MJ, Pettiford BL, Keeley S, et al: Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg 84: 926-932, 2007
11. Onishi H, Shirato H, Nagata Y, et al: Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2:S94-S100, 2007 (suppl 3)
12. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al: Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 75:677-682, 2009
13. López-Encuentra A, García-Luján R, Rivas JJ, et al: Comparison between clinical and pathologic staging in 2,994 cases of lung cancer. Ann Thorac Surg 79:974-979, 2005 (Pubitemid 40288758)
14. Schuchert MJ, Abbas G, Pennathur A, et al: Anatomic lung resection for clinical stage I non-small cell lung cancer (NSCLC): Equivalent outcomes following anatomic segmentectomy and lobectomy. Presented at the American College of Chest Physicians Annual Meeting, Vancouver, British Columbia, Canada, November 4, 2010
15. Baser O: Too much ado about propensity score models? Comparing methods of propensity score matching. Value Health 9:377-385, 2006
16. Austin PC: A critical appraisal of propensityscore matching in the medical literature between 1996 and 2003. Stat Med 27:2037-2049, 2008
17. Dehejia R, Wahba S: Propensity scorematching methods for nonexperimental causal studies. Rev Econ Statistics 84:151-161, 2002
18. Szwerc MF, Landreneau RJ, Santos RS, et al: Minithoracotomy combined with mechanically stapled bronchial and vascular ligation for anatomical lung resection. Ann Thorac Surg 77:1904-1910, 2004 (Pubitemid 38686555)
19. Schuchert MJ, Abbas G, Pettiford BL, et al: Preliminary results of anatomic lung resection using energy-based tissue and vessel coagulative fusion technology. J Thorac Cardiovasc Surg 140:1168- 1173, 2010
20. Sawabata N, Ohta M, Matsumura A,et al: Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: A multicenter prospective study. Ann Thorac Surg 77:415-420, 2004 (Pubitemid 38186481)
21. Clark RE: The Society of Thoracic Surgeons National Database status report. Ann Thorac Surg 57:20-26, 1994
22. Baue AE: Landmark perspective: Evarts A. Graham and the first pneumonectomy. JAMA 251: 261-264, 1984
23. Ellis H: The first pneumonectomies for lung cancer. J Perioper Pract 18:130-131, 2008
24. Archibald E: The technic of total unilateral pneumonectomy. Ann Surg 100:796-811, 1934
25. MacLean LD, Entin MA: Norman Bethune and Edward Archibald: Sung and unsung heroes. Ann Thorac Surg 70:1746-1752, 2000
26. Ochsner A, DeBakey M: Surgical considerations of primary carcinoma of the lung: Review of the literature and report of 19 cases. Surgery 8:992- 1023, 1940
27. Churchill ED, Sweet RH, Soutter L, et al: The surgical management of carcinoma of the lung: A study of the cases treated at the Massachusetts General Hospital from 1930 to 1950. J Thorac Surg 20:349-365, 1950
28. Sone S, Takashima S, Li F, et al: Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 351:1242-1245, 1998 (Pubitemid 28181964)
29. International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, et al: Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355:1763- 1771, 2006
30. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al: Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395-409, 2011
31. Donington JS: Point: Are limited resections appropriate in non-small cell lung cancer? Yes. Chest 141:588-590, 2012
32. Detterbeck FC: Counterpoint: Are limited resections appropriate in non-small cell lung cancer? No: Don't overdo it, and don't get confused. Chest 141:590-592, 2012
33. Keenan RJ, Landreneau RJ, Maley RH Jr, et al: Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg 78:228-233, 2004 (Pubitemid 38833937)
34. El-Sherif A, Gooding WE, Santos R, et al: Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: A 13-year analysis. Ann Thorac Surg 82:408-415, 2006
35. Macke RA, Schuchert MJ, McCormack KN, et al: Long-term impact of anatomic lung resection on pulmonary function. Presented at the 25th Annual Meeting of the General Thoracic Surgery Club, Poster Session, San Diego, CA, March 8, 2012
36. Errett LE, Wilson J, Chiu RC, et al: Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor-risk patients. J Thorac Cardiovasc Surg 90:656-661, 1985 (Pubitemid 16206789)
37. Pastorino U, Valente M, Bedini V, et al: Limited resection for stage I lung cancer. Eur J Surg Oncol 17:42-46, 1991
38. Okada M, Koike T, Higashiyama M, et al: Radical sublobar resection for small-sized non-small cell lung cancer: A multicenter study. J Thorac Cardiovasc Surg 132:769-775, 2006 (Pubitemid 44415874)
39. Donahue JM, Morse CR, Wigle DA, et al: Oncologic efficacy of anatomic segmentectomy in stage IA lung cancer patients with T1a tumors. Ann Thorac Surg 93:381-387, 2012
40. Schuchert MJ, Abbas G, Awais O, et al: Anatomic segmentectomy for the solitary pulmonary nodule and early-stage lung cancer. Ann Thorac Surg 93:1780-1787, 2012
41. Landreneau RJ, Sugarbaker DJ, Mack MJ, et al: Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer. J Thorac Cardiovasc Surg 113:691-698, 1997
42. El-Sherif A, Fernando HC, Santos R, et al: Margin and local recurrence after sublobar resection of non-small cell lung cancer. Ann Surg Oncol 14: 2400-2405, 2007 (Pubitemid 47174921)
43. Litière S, Werutsky G, Fentiman IS, et al: Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol 13:412-419, 2012
44. Darling GE, Allen MS, Decker PA, et al: Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg 141:662-670, 2011
45. Dupuy DE: Image-guided thermal ablation of lung malignancies. Radiology 260:633-655, 2011
46. Timmerman R, McGarry R, Yiannoutsos C, et al: Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24:4833-4839, 2006 (Pubitemid 46630909)
47. Ong CL, Palma D, Verbakel WF, et al: Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): Planning considerations and early toxicity. Radiother Oncol 97:431-436, 2010
48. Lopez Guerra JL, Gomez D, Zhuang Y, et al: Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 83:1573-1579, 2012
49. Rocco G: The surgeon's role in molecular biology. J Thorac Cardiovasc Surg 144:S18-S22, 2012 (suppl)
50. Kim DN, Nam TK, Choe KS, et al: Personalized combined modality therapy for locally advanced non-small cell lung cancer. Cancer Res Treat 44:74- 84, 2012
51. Langer CJ: Individualized therapy for patients with non-small cell lung cancer: Emerging trends and challenges. Crit Rev Oncol Hematol 83:130-144, 2012
52. Salgia R, Hensing T, Campbell N, et al: Personalized treatment of lung cancer. Semin Oncol 38:274-283, 2011
53. Paik PK, Johnson ML, D'Angelo SP, et al: Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas. Cancer 118:5840-5847, 2012